Work

Abstract S1-6: TAMRAD: A GINECO Randomized Phase II Trial of Everolimus in Combination with Tamoxifen Versus Tamoxifen Alone in Patients (pts) with Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer (MBC) with Prior Exposure to Aromatase Inhibitors (AI).

Year: 2010

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs10-s1-6

Authors: T Bachelot, C Bourgier, C Cropet, J-P Guastalla, J-M Ferrero, C Leger-Falandry, P Soulie, J-C Eymard, M Debled, D Spaeth, E Legouffe, T Delozier, C El Kouri, J. Chidiac

Institutions: Institut Gustave Roussy, Centre Léon Bérard, Hôpital Lyon Sud, Centre François Baclesse, Hôtel-Dieu de Paris, Institut Bergonié, Centre Antoine Lacassagne, Institut Jean Godinot

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2048200020

Cites:

Cited by: 59

Related to: 10